These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Specific targeting of mitomycin C to tumors with the use of anti-gastric cancer monoclonal antibody].
    Author: Li S.
    Journal: Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):363-6, 26. PubMed ID: 2171725.
    Abstract:
    In the present study, an anti-gastric cancer monoclonal antibody, MGb2, was chosen to prepare antibody-mitomycin C (MMC) conjugate with dextran T-40 as intermediary. 20 molecules of MMC were introduced into each molecule of antibody, while the antigen-binding capacity of the antibody was kept well. The conjugate showed highly selective cytotoxicity upon human gastric cancer cell line SGC-7901. Radioimmunoimaging and biodistribution studies indicated that after conjugation with MMC via dextran T-40 as intermediary, the tumor localization capacity of the antibody was well retained. When tested in nude mice, by inoculation with human gastric carcinoma SGC-7901 in bilateral subrenal capsules, intraperitoneal injection of the conjugate daily for 6 days at the dose of 1 mg/kg of drug gave a tumor inhibitory rate of 68.67%, the result being far better than that of free MMC or irrelevant conjugate. No synergic effect was found in regard to the mixture of MGb2 with MMC.
    [Abstract] [Full Text] [Related] [New Search]